U.S. News compares companies to their industry peers based on a variety of company fundamentals, performance metrics and investor preferences to help you find the right stocks for your investing style ...
The iShares Biotechnology ETF offers diversified exposure to the biotech sector, focusing on large-cap leaders while maintaining positions in smaller innovators. IBB is cap-weighted and top-heavy, ...
The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed biotechnology stocks, aiming to provide exposure to companies engaged in biotech research, ...
The iShares Biotechnology ETF (IBB) was launched on 02/05/2001, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market. The ETF ...
Following the sale, iShares Biotechnology ETF is comprised 2.67% of DAFNA Capital’s 13F reportable assets under management. Top five holdings after the filing: NASDAQ:RVMD: $48.15 million (11.3% of ...
iShares NASDAQ Biotechnology Index (ETF) IBB traders finally got the breakout they were looking for earlier this month when the ETF surged through the $300 level on strong volume. Benzinga pointed out ...
According to a SEC filing dated November 3, 2025, Florin Court Capital LLP established a new stake in iShares Biotechnology ETF (NASDAQ:IBB) during the third quarter. The firm acquired 77,000 shares, ...
The iShares Biotechnology ETF (IBB) made its debut on 02/05/2001, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market. What Are Smart ...
A smart beta exchange traded fund, the iShares Biotechnology ETF (IBB) debuted on 02/05/2001, and offers broad exposure to the Health Care ETFs category of the market. The ETF industry has long been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results